Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd B Sherer

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Parkinson'S Disease|August 7, 2016
Is Axonal Degeneration a Key Early Event in Parkinson's Disease?Zuzanna Kurowska, Jeffrey H Kordower, A Jon Stoessl, et al.
Disease Models & Mechanisms|September 19, 2013
A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchMarco A S Baptista, Kuldip D Dave, Niketa P Sheth, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 14, 2006
Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Jason R Richardson, W Michael Caudle, Thomas S Guillot, et al.
Plos One|November 19, 2013
Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organsMarco A S Baptista, Kuldip D Dave, Mark A Frasier, et al.
Neurobiology of Disease|January 28, 2006
Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome systemRanjita Betarbet, Rosa M Canet-Aviles, Todd B Sherer, et al.
Neurobiology of Disease|June 28, 2014
Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseKuldip D Dave, Shehan De Silva, Niketa P Sheth, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Parkinson'S Disease|August 7, 2016
Is Axonal Degeneration a Key Early Event in Parkinson's Disease?Zuzanna Kurowska, Jeffrey H Kordower, A Jon Stoessl, et al.
Disease Models & Mechanisms|September 19, 2013
A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchMarco A S Baptista, Kuldip D Dave, Niketa P Sheth, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 14, 2006
Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Jason R Richardson, W Michael Caudle, Thomas S Guillot, et al.
Plos One|November 19, 2013
Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organsMarco A S Baptista, Kuldip D Dave, Mark A Frasier, et al.
Neurobiology of Disease|January 28, 2006
Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome systemRanjita Betarbet, Rosa M Canet-Aviles, Todd B Sherer, et al.
Neurobiology of Disease|June 28, 2014
Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseKuldip D Dave, Shehan De Silva, Niketa P Sheth, et al.
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
Pageof 3